Invesco Dynamic Pharmaceuticals ETF (PJP) Holdings
PJP holdings summary
as of Oct 24, 2026- Holdings
- 28 positions listed
- Top 10 weight
- 50.6% of net assets
- Effective holdings
- 24 equal-weight equivalent
- Largest holding
- ABBV 5.99% AbbVie Inc.
- Annual turnover
- 37.5% of the portfolio traded
All PJP holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | Healthcare | 5.99% | $33.2M | $504.37B | 80.6 |
| 2 | LLY | Eli Lilly and Company | Healthcare | 5.60% | $31.1M | $1.12T | 42.2 |
| 3 | PFE | Pfizer Inc. | Healthcare | 5.57% | $30.9M | $168.60B | 38.9 |
| 4 | GILD | Gilead Sciences, Inc. | Healthcare | 5.53% | $30.7M | $193.67B | — |
| 5 | AMGN | Amgen Inc. | Healthcare | 5.41% | $30.0M | $233.82B | 26.9 |
| 6 | JNJ | Johnson & Johnson | Healthcare | 5.29% | $29.4M | $615.87B | 38.8 |
| 7 | MRK | Merck & Co., Inc. | Healthcare | 5.26% | $29.2M | $360.08B | 115.8 |
| 8 | ABT | Abbott Laboratories | Healthcare | 4.74% | $26.3M | $181.50B | 33.8 |
| 9 | PRGO | Perrigo Company plc | Healthcare | 3.65% | $20.2M | $2.30B | — |
| 10 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 3.59% | $19.9M | $6.68B | 39.1 |
| 11 | VTRS | Viatris Inc. | Healthcare | 3.57% | $19.8M | $21.43B | — |
| 12 | BIIB | Biogen Inc. | Healthcare | 3.36% | $18.7M | $34.37B | 41.3 |
| 13 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 3.32% | $18.4M | $5.89B | 31.1 |
| 14 | UTHR | United Therapeutics Corporation | Healthcare | 3.23% | $17.9M | $22.87B | 19.1 |
| 15 | TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | 3.17% | $17.6M | $3.19B | — |
| 16 | INVA | Innoviva, Inc. | Healthcare | 3.12% | $17.3M | $1.50B | 4.9 |
| 17 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 3.12% | $17.3M | $2.21B | 12.2 |
| 18 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 3.03% | $16.8M | $81.41B | 19.6 |
| 19 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | 3.03% | $16.8M | $1.66B | 15.6 |
| 20 | CORT | Corcept Therapeutics Incorporated | Healthcare | 3.02% | $16.8M | $11.91B | 244.8 |
| 21 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | 2.92% | $16.2M | $2.36B | 14.0 |
| 22 | BMY | Bristol-Myers Squibb Company | Healthcare | 2.77% | $15.4M | $122.05B | 13.2 |
| 23 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 2.68% | $14.9M | $755.0M | 18.3 |
| 24 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 2.55% | $14.2M | $13.65B | 14.4 |
| 25 | TVTX | Travere Therapeutics, Inc. | Healthcare | 2.33% | $13.0M | $4.61B | — |
| 26 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 1.96% | $10.9M | $1.51B | — |
| 27 | LQDA | Liquidia Corporation | Healthcare | 1.59% | $8.9M | $3.07B | 24.7 |
| 28 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | Other | 0.05% | $284,761.80 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($555.1M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PJP sector breakdown
Sum of the weights of the holdings in each sector.
PJP top industries
PJP overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 55.3% | 18 of 50 | 0.57% |
| PBPH | Portfolio Building Block World Pharma and… | 39.7% | 13 of 52 | — |
| IYH | iShares U.S. Healthcare ETF | 38.5% | 15 of 99 | 0.39% |
| TRUH | VanEck Healthcare TruSector ETF | 38.4% | 12 of 60 | — |
| XLV | Health Care Select Sector SPDR Fund | 38.4% | 12 of 60 | 0.09% |
| FHLC | Fidelity MSCI Health Care ETF | 36.8% | 27 of 334 | 0.07% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PJP portfolio
Invesco Dynamic Pharmaceuticals ETF holds 28 positions. The ten largest make up 50.6% of the fund, so it behaves like a portfolio of about 24 equally weighted stocks. The biggest positions are AbbVie Inc. (5.99%), Eli Lilly and Company (5.60%), Pfizer Inc. (5.57%), Gilead Sciences, Inc. (5.53%), Amgen Inc. (5.41%).
By sector, Healthcare is 99.4%, Other is 0.1%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: PJP chart, PJP performance, PJP dividends, PJP overview.
PJP holdings FAQ
How many holdings does PJP have?
PJP holds 28 positions as of October 24, 2026.
What are the top 10 holdings of PJP?
The ten largest holdings are AbbVie Inc. (5.99%), Eli Lilly and Company (5.60%), Pfizer Inc. (5.57%), Gilead Sciences, Inc. (5.53%), Amgen Inc. (5.41%), Johnson & Johnson (5.29%), Merck & Co., Inc. (5.26%), Abbott Laboratories (4.74%), Perrigo Company plc (3.65%), Amneal Pharmaceuticals, Inc. (3.59%). Together they are 50.6% of the fund.
What percentage of PJP is AbbVie Inc.?
AbbVie Inc. is the largest holding at 5.99% of net assets, about $33.2M of the fund's $555.1M.
How concentrated is PJP?
The top 10 holdings are 50.6% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PJP behaves like a portfolio of about 24 equally weighted stocks.